Technology insight: Emerging techniques to predict response to preoperative chemotherapy in breast cancer (Q36303851)

13 August 2017

1 reference

title

Technology insight: Emerging techniques to predict response to preoperative chemotherapy in breast cancer (English)

1 reference

preoperative chemotherapy

13 August 2017

1 reference

2

Luca Gianni

1 reference

13 August 2017

Lajos Pusztai

1

1 reference

13 August 2017

1 November 2004

1 reference

Nature Clinical Practice Oncology

13 August 2017

1 reference

13 August 2017

1

1 reference

13 August 2017

1

1 reference

13 August 2017

44-50

1 reference

Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy

13 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

International expert panel on the use of primary (preoperative) systemic treatment of operable breast cancer: review and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Validation of array-based gene expression profiles by real-time (kinetic) RT-PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Statistical tests for differential expression in cDNA microarray experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Design of studies using DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Estimating dataset size requirements for classifying DNA microarray data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Dendritic cell-based cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Clinical prognostic and predictive factors for primary chemotherapy in operable breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Cell death signaling in maligancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

DNA microarrays in clinical oncology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

A paradigm for class prediction using gene expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Global gene expression changes during neoadjuvant chemotherapy for human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Combined modality management of breast cancer: development of predictive markers through proteomics

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0025

7 January 2021

Identifiers

DOI

10.1038/NCPONC0025

1 reference

13 August 2017

1 reference

PubMed ID

16264799